Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects

The aim of this study was to evaluate the efficacy, optimal dose, and optimal time-window of gacyclidine, a novel N-methyl-D-aspartate (NMDA) receptor antagonist, in terms of its functional, histopathological, and electrophysiological effects after experimental spinal cord injury. The spinal cord of...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2000
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/22409
Acceso en línea:
https://doi.org/10.1089/neu.2000.17.19
https://repository.urosario.edu.co/handle/10336/22409
Palabra clave:
Gacyclidine
N methyl dextro aspartic acid receptor blocking agent
Unclassified drug
Animal experiment
Animal model
Article
Controlled study
Dose response
Evoked somatosensory response
Locomotion
Male
Motor performance
Neuroprotection
Nonhuman
Rat
Spinal cord injury
Spinal cord lesion
Dose-window
Gacyclidine
N-methyl-d-aspartate
Photochemical lesion
Secondary injury
Spinal cord injury
Time-window
Rights
License
Abierto (Texto Completo)
id EDOCUR2_4ba52327ef5d75642a04475b077aa47a
oai_identifier_str oai:repository.urosario.edu.co:10336/22409
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling d7a8cbc2-7ad1-4f09-9337-8b09e943b216-1a508ac53-7ecd-4292-9b1f-0cf2af78ee78-1ebe6d87d-809a-4133-a57a-30d5755cadcf-1cb245eb4-1a22-48de-88fd-e9c86afea8e4-18e3b23ad-e96c-4289-b0f3-aef6a29a3397-1ad20bc2d-6ded-4d82-bf07-001e72674d67-12020-05-25T23:56:22Z2020-05-25T23:56:22Z2000The aim of this study was to evaluate the efficacy, optimal dose, and optimal time-window of gacyclidine, a novel N-methyl-D-aspartate (NMDA) receptor antagonist, in terms of its functional, histopathological, and electrophysiological effects after experimental spinal cord injury. The spinal cord of rats was damaged by a photochemical method and the animals were treated by saline or gacyclidine at doses of 1, 2.5, or 5 mg/kg 10 min after injury or gacyclidine 1 mg/kg 10, 30, 60, and 120 min after injury. The time-course of the motor score (walking and inclined-plane stability) was evaluated until day 18, and somatosensory evoked potentials were determined on day 18. The animals were then sacrificed, and the cross-sectional area of the spinal cord (at the epicenter of the injury, above and below the injury) was measured. Walking recovery was better in most of the groups treated after injury than in the untreated injured animals. Motor performances were related to preservation of a larger undamaged area of spinal cord at the level of the injury and, interestingly, with prevention of extension of the anatomical lesion above the level of the injury. Somatosensory evoked potential amplitudes were often higher in treated groups. These results confirm that gacyclidine induces dose-dependent and time-dependent attenuation of spinal cord damage after an experimental vascular lesion. Although all three doses induced neuroprotective effects, recovery was greater and very homogeneous in the group treated with 1 mg/kg. Moreover, recovery was slightly better and more homogeneous within the groups treated 10 and 30 min after injury compared to the other groups. It appears that, according to the existing evidence, NMDA antagonists are an essential component in the elaboration of a neuroprotective strategy after spinal cord trauma.application/pdfhttps://doi.org/10.1089/neu.2000.17.198977151https://repository.urosario.edu.co/handle/10336/22409engMary Ann Liebert Inc.30No. 119Journal of NeurotraumaVol. 17Journal of Neurotrauma, ISSN:8977151, Vol.17, No.1 (2000); pp. 19-30https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033973993&doi=10.1089%2fneu.2000.17.19&partnerID=40&md5=c614f5a1f17680852997dea2f03da2b7Abierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURGacyclidineN methyl dextro aspartic acid receptor blocking agentUnclassified drugAnimal experimentAnimal modelArticleControlled studyDose responseEvoked somatosensory responseLocomotionMaleMotor performanceNeuroprotectionNonhumanRatSpinal cord injurySpinal cord lesionDose-windowGacyclidineN-methyl-d-aspartatePhotochemical lesionSecondary injurySpinal cord injuryTime-windowNeuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effectsarticleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Gaviria M.Privat A.D'Arbigny P.Kamenka J.-M.Haton H.Ohanna F.10336/22409oai:repository.urosario.edu.co:10336/224092022-05-02 07:37:14.153024https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
title Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
spellingShingle Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
Gacyclidine
N methyl dextro aspartic acid receptor blocking agent
Unclassified drug
Animal experiment
Animal model
Article
Controlled study
Dose response
Evoked somatosensory response
Locomotion
Male
Motor performance
Neuroprotection
Nonhuman
Rat
Spinal cord injury
Spinal cord lesion
Dose-window
Gacyclidine
N-methyl-d-aspartate
Photochemical lesion
Secondary injury
Spinal cord injury
Time-window
title_short Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
title_full Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
title_fullStr Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
title_full_unstemmed Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
title_sort Neuroprotective effects of gacyclidine after experimental photochemical spinal cord lesion in adult rats: Dose-window and time-window effects
dc.subject.keyword.spa.fl_str_mv Gacyclidine
N methyl dextro aspartic acid receptor blocking agent
Unclassified drug
Animal experiment
Animal model
Article
Controlled study
Dose response
Evoked somatosensory response
Locomotion
Male
Motor performance
Neuroprotection
Nonhuman
Rat
Spinal cord injury
Spinal cord lesion
Dose-window
Gacyclidine
N-methyl-d-aspartate
Photochemical lesion
Secondary injury
Spinal cord injury
Time-window
topic Gacyclidine
N methyl dextro aspartic acid receptor blocking agent
Unclassified drug
Animal experiment
Animal model
Article
Controlled study
Dose response
Evoked somatosensory response
Locomotion
Male
Motor performance
Neuroprotection
Nonhuman
Rat
Spinal cord injury
Spinal cord lesion
Dose-window
Gacyclidine
N-methyl-d-aspartate
Photochemical lesion
Secondary injury
Spinal cord injury
Time-window
description The aim of this study was to evaluate the efficacy, optimal dose, and optimal time-window of gacyclidine, a novel N-methyl-D-aspartate (NMDA) receptor antagonist, in terms of its functional, histopathological, and electrophysiological effects after experimental spinal cord injury. The spinal cord of rats was damaged by a photochemical method and the animals were treated by saline or gacyclidine at doses of 1, 2.5, or 5 mg/kg 10 min after injury or gacyclidine 1 mg/kg 10, 30, 60, and 120 min after injury. The time-course of the motor score (walking and inclined-plane stability) was evaluated until day 18, and somatosensory evoked potentials were determined on day 18. The animals were then sacrificed, and the cross-sectional area of the spinal cord (at the epicenter of the injury, above and below the injury) was measured. Walking recovery was better in most of the groups treated after injury than in the untreated injured animals. Motor performances were related to preservation of a larger undamaged area of spinal cord at the level of the injury and, interestingly, with prevention of extension of the anatomical lesion above the level of the injury. Somatosensory evoked potential amplitudes were often higher in treated groups. These results confirm that gacyclidine induces dose-dependent and time-dependent attenuation of spinal cord damage after an experimental vascular lesion. Although all three doses induced neuroprotective effects, recovery was greater and very homogeneous in the group treated with 1 mg/kg. Moreover, recovery was slightly better and more homogeneous within the groups treated 10 and 30 min after injury compared to the other groups. It appears that, according to the existing evidence, NMDA antagonists are an essential component in the elaboration of a neuroprotective strategy after spinal cord trauma.
publishDate 2000
dc.date.created.spa.fl_str_mv 2000
dc.date.accessioned.none.fl_str_mv 2020-05-25T23:56:22Z
dc.date.available.none.fl_str_mv 2020-05-25T23:56:22Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1089/neu.2000.17.19
dc.identifier.issn.none.fl_str_mv 8977151
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/22409
url https://doi.org/10.1089/neu.2000.17.19
https://repository.urosario.edu.co/handle/10336/22409
identifier_str_mv 8977151
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 30
dc.relation.citationIssue.none.fl_str_mv No. 1
dc.relation.citationStartPage.none.fl_str_mv 19
dc.relation.citationTitle.none.fl_str_mv Journal of Neurotrauma
dc.relation.citationVolume.none.fl_str_mv Vol. 17
dc.relation.ispartof.spa.fl_str_mv Journal of Neurotrauma, ISSN:8977151, Vol.17, No.1 (2000); pp. 19-30
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-0033973993&doi=10.1089%2fneu.2000.17.19&partnerID=40&md5=c614f5a1f17680852997dea2f03da2b7
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Mary Ann Liebert Inc.
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1818106679347118080